Study finds melatonin eases sleep woes in children with autism

January 9, 2012

(Medical Xpress) -- A new Vanderbilt study shows that the over-the-counter supplement melatonin is promising in helping children with autism spectrum disorders (ASD), and their families, sleep better.

The study, published in the , contributes to the growing literature on supplemental for in ASD, according to lead author Beth Malow, M.D., M.S., professor of Neurology and Pediatrics, Burry Chair in Cognitive and Vanderbilt Kennedy Center investigator.

Malow said the study was designed to allow researchers to identify doses at which children responded to melatonin and also how long it took to observe a response.

, particularly insomnia, occur in 50 percent to 80 percent of children with ASD and are often accompanied by child and family distress.

“We are excited about the potential melatonin has for treating insomnia, which can be overwhelming to children with autism as well as their families,” Malow said. “The next step is to perform large-scale, controlled trials to prove that melatonin is effective in this population.”

Malow and colleagues recruited children ages 3-9 years with a clinical diagnosis of an ASD whose parents reported sleep onset delay of 30 minutes or longer on three or more nights per week.

Supplemental melatonin, given 30 minutes before bedtime, improved sleep latency in most children at 1 mg or 3 mg dosages.

Sleep latency, or the amount of time it takes a child to fall asleep, was measured by using an actigraph, which is a wrist-watch-like sensor worn by participants to monitor human rest/activity cycles.

Melatonin was effective in the first week of treatment, maintained effectiveness over several months, was well-tolerated and safe, and showed improvement in sleep, behavior and parenting stress, Malow said.

“While supplemental melatonin has shown promise in treating insomnia in our work and those of others, it is important that individuals with insomnia seek medical advice before taking melatonin,” Malow said. “This is because other treatable medical and sleep conditions can sometimes cause insomnia. Also, melatonin can interact with other drugs for other medical conditions."

Explore further: Tireless research reveals secrets of the 'sleep hormone'

Related Stories

Tireless research reveals secrets of the 'sleep hormone'

December 13, 2011

A team from the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University has made a major breakthrough by unraveling the inner workings of melatonin, also known as the "sleep hormone." The ...

Recommended for you

Autism biomarker seen as boon for new treatments

January 11, 2017

Researchers at the UCLA Center for Autism Research and Treatment have identified a signature brain-wave pattern for children with autism spectrum disorder related to a genetic condition known as Dup15q syndrome. The research ...

Lab confirms vitamin D link to autism traits

December 14, 2016

Researchers at The University of Queensland's Queensland Brain Institute have found a link between vitamin D deficiency in pregnancy and increased autism traits.

Neuromotor problems at the core of autism, study says

December 12, 2016

Rutgers neuroscientists have established that problems controlling bodily movements are at the core of autism spectrum disorders and that the use of psychotropic medications to treat autism in children often makes such neuromotor ...

Mutations in life's 'essential genes' tied to autism

December 12, 2016

Genes known to be essential to life—the ones humans need to survive and thrive in the womb—also play a critical role in the development of autism spectrum disorder (ASD), suggests a new study from Penn Medicine geneticists ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.